Analysis of patients with malignant and paramalignant pleural effusion.

被引:0
|
作者
Cakmak, Muharrem [1 ]
Durkan, Atilla [1 ]
机构
[1] Gazi Yasargil Educ & Res Hosp, Thorac Surg Clin, Diyarbakir, Turkey
来源
BIOMEDICAL RESEARCH-INDIA | 2017年 / 28卷 / 05期
关键词
Malignant; Paramalignant; Effusion;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
While the malignant cells in the fluid are available in malignant pleural effusions (MPE), in paramalignant pleural effusions (PMPE), the malignant cells do not exist. We aimed to compare the results of patients with MPE and PMPE. Materials and methods: 134 patients (MPE: 106 PMPE: 28) were analysed retrospectively. Patients were divided into 2 groups as MPE, and PMPE. Results were analysed. P<0.05 was considered significant. Results: 65 of the patients with MPE were malignant mesothelioma (MM), while 41 of them were pleural metastasis. 28 of patients were PMPE. Male gender, right localization and exudative feature were found to be significant for patients with MPE. On the other hand, pleural effusion having exudative feature was significant for patients with PMPE. MM, chondrosarcoma, lung and liver cancer were found to be more effective in the formation MPE. Mortality was higher in patients with MPE (n=4). Tube thoracostomy was found as primary treatment method in treatment of patients with MPE. Conclusion: MPE and PMPE are caused by underlying malignant diseases. The mortality rate is higher in patients with pleural metastatic. Tube thoracostomy and pleurodesis are the primary treatment methods.
引用
收藏
页码:2226 / 2229
页数:4
相关论文
共 50 条
  • [21] Characteristics of patients with myelomatous pleural effusion. A systematic review
    Riveiro, V.
    Ferreiro, L.
    Toubes, M. E.
    Lama, A.
    Alvarez-Dobano, J. M.
    Valdes, L.
    REVISTA CLINICA ESPANOLA, 2018, 218 (02): : 89 - 97
  • [22] Two cases of cholesterin pleural effusion.
    Sharpe, H
    BMJ-BRITISH MEDICAL JOURNAL, 1919, 1919 : 462 - 463
  • [23] Pleural effusion. An unfamiliar presentation of ABPA
    Kaur, Komaldeep
    Gupta, Aditi
    Kaur, Gagandeep
    Chopra, Vishal
    MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (04) : 553 - 556
  • [24] Atypical Presentation of Tuberculous Pleural Effusion.
    Madhumidha, K.
    Padma, V.
    Karthikeyan, R.
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (06): : 1126 - 1129
  • [25] Not a Parapneumonia Pleural Effusion. It Was a Neuroendocrine Carcinoma
    Rodriguez, W.
    Cantres, O. J.
    Ortiz-Bonilla, M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [26] Pleural effusion. Rational diagnosis and therapy
    Hamm, H.
    PNEUMOLOGE, 2007, 4 (05): : 357 - 370
  • [27] DASATINIB AND PLEURAL EFFUSION. EXPERIENCE OF A CENTRE
    Lopez Raul, Perez
    Fierrez Eduardo, Salido
    Perianes Valentin, Cabanas
    Piqueras Mercedes, Berenguer
    Candel Faustino, Garcia
    Blanquer Miguel, Blanquer
    Juan Jose, Cerezo Manchado
    Marin Amelia, Martinez
    Arnao Maria, Moya
    Mitat Alina, Ramon
    Ana Maria, Garcia Hernandez
    Garcia Consuelo, Gonzalez
    Maria Jose, Moreno Belmonte
    Francesca, Labbadia
    Amor Antonia, Melero
    Poveda Elena, Fernandez
    Jose Maria, Moraleda Jimenez
    HAEMATOLOGICA, 2016, 101 : 349 - 349
  • [28] Survival of malignant and paramalignant pleural effusions in Ouagadougou
    Bambara, A. T.
    Ouedraogo, S. M.
    Maiga, S.
    Sondo, K. A.
    Nikiema, K. Boncoungou
    Ouedraogo, G.
    Koumbem, B.
    Ouedraogo, A. S.
    Djibril, M.
    Badoum, G.
    Ouedraogo, A. R.
    Ouedraogo, M.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2016, 72 (06) : 346 - 352
  • [29] Talc Versus Minocycline and OK-432 Pleurodesis for Malignant Pleural Effusion.
    Mochizuki, E.
    Mochizuka, Y.
    Oishi, K.
    Naoi, H.
    Matsuura, S.
    Mikura, S.
    Nagaoka, M.
    Tsukui, M.
    Koshimizu, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S895 - S895
  • [30] Intraperitoneal and intrapleural administrations of triamcinolone acetonide for control of malignant ascites and pleural effusion.
    Inoue, K.
    Tsubamoto, H.
    Ito, K.
    Hori, K.
    Kanazawa, R.
    Ito, Y.
    Yamamoto, S.
    Onishi, K.
    Ando, R.
    Komori, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)